This article reads like a press release or a news article and may be largely based on routine coverage. Please help improve this article and add independent sources. (October 2017)
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (June 2011) (Learn how and when to remove this template message)

The Eastern Cooperative Oncology Group (ECOG) began in 1955 as one of the first publicly funded cooperative groups to perform multi-center clinical trials for cancer research.[1] A cooperative group in oncology constitutes a large network of private and public medical institutions developing protocols for cancer treatments. Institutional members include universities, medical centers, governments, and other cooperative groups. Research results are often provided through scientific publications, but the group also works closely with the pharmaceutical industry to test potential cancer drugs.

Eastern Cooperative Oncology Group

According to ECOG's website, there are "more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up."[2]

ECOG's coordinating center is based in Boston, Massachusetts while its Group Chair's office is located in Philadelphia, Pennsylvania.

References

  1. ^ Crystal Phend (March 24, 2008). "NCI-Sponsored Cancer Trials Offer Decent Clinical Return on Investment". MedPage Today. Retrieved September 17, 2016.
  2. ^ "Introduction to ECOG". June 6, 2006. Archived from the original on May 20, 2013.

External links

More
Scholia has a profile for Eastern Cooperative Oncology Group (Q5330089).
Categories